BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21252160)

  • 1. Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.
    Wang X; Liu X; Li AY; Chen L; Lai L; Lin HH; Hu S; Yao L; Peng J; Loera S; Xue L; Zhou B; Zhou L; Zheng S; Chu P; Zhang S; Ann DK; Yen Y
    Clin Cancer Res; 2011 Apr; 17(8):2570-80. PubMed ID: 21252160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.
    Liu Z; Wu K; Yang Z; Wu A
    Mol Cell Biochem; 2015 Nov; 409(1-2):155-62. PubMed ID: 26183485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
    Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression.
    Binabaj MM; Soleimani A; Rahmani F; Avan A; Khazaei M; Fiuji H; Soleimanpour S; Ryzhikov M; Ferns GA; Bahrami A; Hassanian SM
    Gene; 2019 Jul; 706():131-139. PubMed ID: 31055021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
    Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
    J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer.
    Liu X; Lai L; Wang X; Xue L; Leora S; Wu J; Hu S; Zhang K; Kuo ML; Zhou L; Zhang H; Wang Y; Wang Y; Zhou B; Nelson RA; Zheng S; Zhang S; Chu P; Yen Y
    Cancer Res; 2011 May; 71(9):3202-13. PubMed ID: 21415168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers.
    Liu X; Zhang H; Lai L; Wang X; Loera S; Xue L; He H; Zhang K; Hu S; Huang Y; Nelson RA; Zhou B; Zhou L; Chu P; Zhang S; Zheng S; Yen Y
    Clin Sci (Lond); 2013 May; 124(9):567-78. PubMed ID: 23113760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer.
    Wu J; Zhang S; Shan J; Hu Z; Liu X; Chen L; Ren X; Yao L; Sheng H; Li L; Ann D; Yen Y; Wang J; Wang X
    Cancer Lett; 2016 Jul; 376(2):284-92. PubMed ID: 27063096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis.
    Raskin L; Fullen DR; Giordano TJ; Thomas DG; Frohm ML; Cha KB; Ahn J; Mukherjee B; Johnson TM; Gruber SB
    J Invest Dermatol; 2013 Nov; 133(11):2585-2592. PubMed ID: 23633021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
    Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
    Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
    Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
    Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating cell-free high mobility group AT-hook 2 mRNA as a detection marker in the serum of colorectal cancer patients.
    Sahengbieke S; Wang J; Li X; Wang Y; Lai M; Wu J
    J Clin Lab Anal; 2018 May; 32(4):e22332. PubMed ID: 28948632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression.
    Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
    Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
    Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.